The Precision Health Operating System for cardiometabolic risk modelling. LifeMesh AI builds a Personal Health Twin — a living forecast of a person's health — starting with cardiometabolic risk: type 2 diabetes and cardiovascular disease, together.
Illustrative. A single test is a snapshot; a health twin is the film — so small changes can be made early, with the clinician, while they matter most.
A dashboard shows today's numbers. A twin models the person over time — a risk trajectory, scenario simulation and evidence-linked explanations, all on a consent layer the person owns. The person owns the data, the clinician supervises the care, the payer funds the outcome.
Surface cardiometabolic risk years earlier, from records that already exist — no new hardware.
Turn risk into a clinician-supervised prevention plan — decision support, never autonomous diagnosis.
Track outcomes and cost avoided at cohort level, on validated, auditable, published models.
Engineered in Melbourne, in collaboration with leading clinical specialists across cardiac surgery, cardiology and endocrinology.
We're pre-seed and building deliberately. We're opening a small number of conversations with the partners who shape this well.
Our detailed materials — platform briefing, clinical approach and investor deck — sit in a secure briefing room. Tell us who you are and we'll send access to your work email.
Work email preferred. We review each request individually. Materials are Commercial-in-Confidence and shared under a briefing agreement. By requesting access you agree we may contact you about LifeMesh AI — see our privacy note.